Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial

Rationale: Targeted lung denervation (TLD) is a bronchoscopic radiofrequency ablation therapy for chronic obstructive pulmonary disease (COPD), which durably disrupts parasympathetic pulmonary nerves to decrease airway resistance and mucus hypersecretion. Objectives: To determine the safety and impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Slebos, Dirk-Jan, Shah, Pallav L., Herth, Felix J. F., Pison, Christophe, Schumann, Christian, Hübner, Ralf-Harto, Bonta, Peter I., Kessler, Romain, Gesierich, Wolfgang, Darwiche, Kaid, Lamprecht, Bernd, Perez, Thierry, Skowasch, Dirk, Deslee, Gaetan, Marceau, Armelle, Sciurba, Frank C., Gosens, Reinoud, Hartman, Jorine E., Srikanthan, Karthi, Duller, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909835/
https://www.ncbi.nlm.nih.gov/pubmed/31404499
http://dx.doi.org/10.1164/rccm.201903-0624OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909835/
https://www.ncbi.nlm.nih.gov/pubmed/31404499
http://dx.doi.org/10.1164/rccm.201903-0624OC

Ejemplares similares